LYEL
Price
$11.06
Change
-$0.04 (-0.36%)
Updated
Aug 29, 04:04 PM (EDT)
Capitalization
216.7M
VCYT
Price
$30.27
Change
+$0.32 (+1.07%)
Updated
Aug 29, 04:23 PM (EDT)
Capitalization
2.36B
74 days until earnings call
Interact to see
Advertisement

LYEL vs VCYT

Header iconLYEL vs VCYT Comparison
Open Charts LYEL vs VCYTBanner chart's image
Lyell Immunopharma
Price$11.06
Change-$0.04 (-0.36%)
Volume$100
Capitalization216.7M
Veracyte
Price$30.27
Change+$0.32 (+1.07%)
Volume$700
Capitalization2.36B
LYEL vs VCYT Comparison Chart in %
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYEL vs. VCYT commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a Buy and VCYT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (LYEL: $11.10 vs. VCYT: $29.95)
Brand notoriety: LYEL and VCYT are both not notable
LYEL represents the Biotechnology, while VCYT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LYEL: 15% vs. VCYT: 64%
Market capitalization -- LYEL: $216.7M vs. VCYT: $2.36B
LYEL [@Biotechnology] is valued at $216.7M. VCYT’s [@Medical Specialties] market capitalization is $2.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B. The average market capitalization across the [@Medical Specialties] industry is $10.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, both LYEL and VCYT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 3 TA indicator(s) are bullish while VCYT’s TA Score has 5 bullish TA indicator(s).

  • LYEL’s TA Score: 3 bullish, 5 bearish.
  • VCYT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than LYEL.

Price Growth

LYEL (@Biotechnology) experienced а +4.23% price change this week, while VCYT (@Medical Specialties) price change was +1.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.74%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +29.97%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.31%. For the same industry, the average monthly price growth was +7.89%, and the average quarterly price growth was +7.74%.

Reported Earning Dates

VCYT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (-0.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (-0.31% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($2.36B) has a higher market cap than LYEL($217M). LYEL YTD gains are higher at: -13.281 vs. VCYT (-24.369). VCYT has higher annual earnings (EBITDA): 52M vs. LYEL (-199.95M). VCYT has more cash in the bank: 321M vs. LYEL (277M). LYEL has less debt than VCYT: LYEL (46.6M) vs VCYT (50.6M). VCYT has higher revenues than LYEL: VCYT (479M) vs LYEL (60K).
LYELVCYTLYEL / VCYT
Capitalization217M2.36B9%
EBITDA-199.95M52M-385%
Gain YTD-13.281-24.36955%
P/E RatioN/A88.09-
Revenue60K479M0%
Total Cash277M321M86%
Total Debt46.6M50.6M92%
FUNDAMENTALS RATINGS
VCYT: Fundamental Ratings
VCYT
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYELVCYT
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 17 days ago
72%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QIACX52.62N/A
N/A
Federated Hermes MDT All Cap Core IS
TRPWX23.58N/A
N/A
Nuveen Quant Mid Cap Growth R6
TRMCX33.10N/A
N/A
T. Rowe Price Mid-Cap Value
HNVIX36.62N/A
N/A
Heartland Value Plus Institutional
STRNX58.68N/A
N/A
Sterling Capital MdCp Relatv Val C

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
-1.60%
VCYT - LYEL
46%
Loosely correlated
+4.68%
CRBU - LYEL
40%
Loosely correlated
-2.02%
BEAM - LYEL
39%
Loosely correlated
-0.06%
TYRA - LYEL
37%
Loosely correlated
-3.96%
ZNTL - LYEL
36%
Loosely correlated
-3.30%
More

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been closely correlated with NTLA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if VCYT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
+4.68%
NTLA - VCYT
69%
Closely correlated
+1.58%
VCEL - VCYT
60%
Loosely correlated
N/A
AXON - VCYT
58%
Loosely correlated
+1.59%
DNA - VCYT
57%
Loosely correlated
-1.46%
ABCL - VCYT
55%
Loosely correlated
-1.15%
More